BioSpace News Archive

Press Releases

Kiora Pharmaceuticals Reports Third Quarter Results; Retinal Disease Pipeline Advancing Two Phase 2 Studies

November 8, 2024
·
11 min read
Press Releases

iSpecimen Named Top Competitor in $4.4 Billion USD Market

Biospecimen Market To Exceed $13.5 Billion USD By 2032

November 8, 2024
·
4 min read
Press Releases

Palleon Pharmaceuticals Presents Results from the Phase 1/2 GLIMMER-01 Trial of E-602 in Combination with Cemiplimab in Patients with Solid Tumors at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 8, 2024
·
3 min read
Press Releases

HistoIndex to Present Latest Findings on AI-based Analysis using Stain-free Digital Pathology with 12 Accepted Abstracts at AASLD The Liver Meeting® 2024

November 8, 2024
·
6 min read
Press Releases

Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting

November 8, 2024
·
10 min read
Press Releases

Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 8, 2024
·
9 min read
Press Releases

Ellis Bio Launches to Transform Epigenomics Research with SuperMethyl - Fast Kit Debut

November 8, 2024
·
1 min read
Press Releases

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition in murine models of breast, colorectal, and prostate cancers

November 8, 2024
·
3 min read